Phase
Condition
Prostate Cancer
Prostate Disorders
Urologic Cancer
Treatment
FocalOne
Clinical Study ID
Ages > 18 Male
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Patient eligible for HIFU treatment for prostate cancer, excluding whole glandtreatment.
Patient newly diagnosed with localized prostate cancer confirmed with an imageguided biopsy (MRI and/or micro-ultrasounds).
Gleason ≤ 4+3.
Patient scheduled for HIFU treatment as determined by the physician.
Patient with healthcare coverage. Spanish-speaking patients with the ability toprovide informed written consent
Exclusion
Exclusion Criteria:
Patient with bilateral prostate cancer requiring whole gland treatment.
Patients clinically detected metastasis.
Patient with an extension of cancer or seminal vesicle invasion.
Patient with contraindications for HIFU treatment: please refer to the completeFocal One user manual.
Study Design
Connect with a study center
Hospital Universitario Puerta del Mar
Cadiz, 21 11009
SpainSite Not Available
Hospital General Universitario Gregorio Marañón C/ Doctor Esquerdo
Madrid, 46 28007
SpainSite Not Available
Hospital Universitario Central De Asturias
Oviedo, 33011
SpainSite Not Available
Hospital Universitario Marqués De Valdecilla
Santander, 39008
SpainSite Not Available
Hospital Consorcio General Universitario de Valencia
Valencia, 46014
SpainSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.